A Study to Compare the Efficacy and Safety of LY01015 and Opdivo ® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma Interventions: Drug: LY01015; Drug: Fluorouracil; Drug: Cisplatin; Drug: Opdivo® Sponsor: Shandong Boan Biotechnology Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Research | Skin Cancer | Squamous Cell Carcinoma | Study